Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Inbar

Showing results (171-180 of 176) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 176 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2009
Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variantM J Hall, E Liberman, O Dulkart, et al.
Bone Marrow Transplantation|April 15, 2003
Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patientsS M Stemmer, I Hardan, H Raz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancerM E R O'Brien, N Wigler, M Inbar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2O Merimsky, E Gez, R Weitzen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2018
Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancerE Evron, A M Ben-David, H Goldberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancerE Vrdoljak, N Marschner, C Zielinski, et al.
Pageof 18

Showing results (171-180 of 176) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 176 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2009
Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variantM J Hall, E Liberman, O Dulkart, et al.
Bone Marrow Transplantation|April 15, 2003
Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patientsS M Stemmer, I Hardan, H Raz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancerM E R O'Brien, N Wigler, M Inbar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2O Merimsky, E Gez, R Weitzen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2018
Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancerE Evron, A M Ben-David, H Goldberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancerE Vrdoljak, N Marschner, C Zielinski, et al.
Pageof 18